The Dutch Medicinal Chemistry & Chemical Biology landscape in the wake of the Corona pandemic
| Start | |
| 10.00 | Welcome (coffee & tea) |
| 10.20 | Introduction by Iwan de Esch on behalf of KNCV-MCCB |
| Morning session. Chair: Tom Grossmann (VU) | |
| 10.30 | Nathaniel Martin (UL) Semisynthetic lipopeptide antibiotics that overcome multi-drug resistance in clinically relevant pathogens |
| 10.55 | Ingrid Dijkgraaf (MU) Immunomodulatory proteins from tick saliva |
| 11.20 | Seino Jongkees (VU) De novo macrocyclic peptides (and beyond?) |
| 11.45 | Jan van Maarseveen (UvA) Tying molecular ropes: synthetic methodology development towards lasso peptides |
| 12.10 | Lunch, KNCV-MCCB board meeting for members, posters for others. |
| Afternoon session. Chair: Martine Smit (VU) |
|
| 13.15 | Raimond Heukers (VU/QVQ Holding) Targeting/modulating GPCRs outside in and inside out |
| 13.40 | Bauke Albada (WUR) Catalytic DNA nanostructures that modify wild-type proteins |
| 14.05 | Anita Wegert (Symeres) Unlocking drug discovery power through collaborative efforts between academia and CRO : bringing novel tankyrase inhibitors towards the clinic. |
| 14.30 | Coffee & Tea |
| 15.00 | Kim Bonger (RU) Chemoenzymatic tools for targeted drug delivery |
| 15.25 | Loes Stevers (Tue/Ambagon) Molecular glues targeting the 14-3-3/CFTR complex |
| 15.50 | Alexander Dömling (RUG) AUTOMATION + MINIATURIZATION = ACCELERATION: From automated nanoscale synthesis to potent SARS-CoV2 3CLpro |
| 16.15 | Closure and Drinks |
